Literature DB >> 23471615

Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration.

Valtteri Kaasinen, Maria Gardberg, Matias Röyttä, Marko Seppänen, Markku Päivärinta.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23471615     DOI： 10.1007/s00415-013-6886-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  3 in total

1.  Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration.

Authors:  Sean S O'Sullivan; David J Burn; Janice L Holton; Andrew J Lees
Journal:  Mov Disord       Date:  2008-12-15       Impact factor: 10.338

2.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.

Authors:  Andrea Varrone; John C Dickson; Livia Tossici-Bolt; Terez Sera; Susanne Asenbaum; Jan Booij; Ozlem L Kapucu; Andreas Kluge; Gitte M Knudsen; Pierre Malick Koulibaly; Flavio Nobili; Marco Pagani; Osama Sabri; Thierry Vander Borght; Koen Van Laere; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-16       Impact factor: 9.236

3.  Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.

Authors:  Roberto Cilia; Carlo Rossi; Daniela Frosini; Duccio Volterrani; Chiara Siri; Cristina Pagni; Riccardo Benti; Gianni Pezzoli; Ubaldo Bonuccelli; Angelo Antonini; Roberto Ceravolo
Journal:  PLoS One       Date:  2011-05-02       Impact factor: 3.240
  3 in total
  5 in total

Review 1.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

Review 2.  Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT.

Authors:  Balestrino Roberta; Barone Paolo; Filippi Massimo; Erro Roberto
Journal:  J Neurol       Date:  2021-09-18       Impact factor: 6.682

3.  Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.

Authors:  Simon Badoud; Dimitri Van De Ville; Nicolas Nicastro; Valentina Garibotto; Pierre R Burkhard; Sven Haller
Journal:  Neuroimage Clin       Date:  2016-07-05       Impact factor: 4.881

Review 4.  Neurotransmitter deficits from frontotemporal lobar degeneration.

Authors:  Alexander G Murley; James B Rowe
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

5.  Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients.

Authors:  San San Xu; Paschal K Alexander; Yenni Lie; Vincent Dore; Svetlana Bozinovski; Rachel S Mulligan; Kenneth Young; Victor L Villemagne; Christopher C Rowe
Journal:  BMJ Open       Date:  2018-11-15       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.